OpGen

OpGen EPS

The Earnings per Share (EPS) of OpGen (OPGN) as of Oct 19, 2026 is 2.35 USD. In the previous year, Earnings per Share (EPS) was 1.19 USD — a change of 96.94% (higher).

EPS

2.35USD

YoY

96.94%

Last updated:

Earnings per Share (EPS) of OpGen is 2025 2.35 USD. Earnings per Share (EPS) of OpGen was 2024 1.19 USD. It decreases by 96.94% higher compared to the previous year.

The OpGen EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2018
-671.76 USD
Jan 1, 2019
-598.37 USD
Jan 1, 2020
-248.92 USD
Jan 1, 2021
-172.14 USD
Jan 1, 2022
-137.02 USD
Jan 1, 2023
-25.47 USD
Jan 1, 2024
1.19 USD
Jan 1, 2025
2.35 USD
The OpGen EPS history
YEAREPSYoY
2.35USD+96.94%
1.19USD-104.68%
-25.47USD-81.41%
-137.02USD-20.40%
-172.14USD-30.85%
-248.92USD-58.40%
-598.37USD-10.93%
-671.76USD-76.00%
-2,798.70USD-95.62%
-63,889.18USD+820.49%
-6,940.80USD+10.15%
-6,301.11USD+735,267.93%
-0.86USD-28.67%
-1.20USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OpGen Stock analysis

What does OpGen do? OpGen Inc is a biotechnology company based in Gaithersburg, Maryland, operating within the Health Care sector. The company went public on May 5, 2015, with ticker OPGN and ISIN US68373L5057. It currently employs three people. OpGen develops molecular information solutions focused on combating infectious diseases in global healthcare settings. The company's technology involves DNA tests and bioinformatics to address antibiotic resistance, assisting healthcare providers in managing patient care decisions and monitoring the spread of multidrug-resistant microorganisms. Its solutions aim to guide clinicians with information about life-threatening infections and help manage patient outcomes. The company's website is http://opgen.com/. OpGen is engaged in creating tools to help protect the hospital biome through customized screening and surveillance. The firm markets its high-resolution DNA tests under the Acuitas trade name. The company has a global network of customers and partners. OpGen does not provide specific details on its product names beyond Acuitas, and no additional financial figures or historical data are available in the provided information. OpGen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OpGen stock

Earnings per Share (EPS) of OpGen is 2.35 USD in 2025.

Earnings per Share (EPS) of OpGen changed from 1.19 USD to 2.35 USD, representing a 96.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) OpGen since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — OpGen

All Key Metrics — OpGen